Stock PBIO PRESSURE BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Pressure BioSciences, Inc.

Equities

PBIO

US74112E2081

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets
Other stock markets
 12:55:40 2024-06-28 EDT 		5-day change 1st Jan Change
0.1273 USD -9.01% Intraday chart for Pressure BioSciences, Inc. -5.70% -61.42%
06-25 Pressure BioSciences, Inc. Partners with Vita-Forte to Commercialize Highly Potent, Multi-Antioxidant, UST Nanoemulsion Oral Spray CI
06-20 Transcript : Pressure BioSciences, Inc. - Special Call

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 3.942 3 8.309 18.35 15.89 7.769
Enterprise Value (EV) 1 8.843 10.93 17.89 32.86 36.41 30.57
P/E ratio -0.15 x -0.16 x -0.4 x -0.68 x -0.81 x -0.22 x
Yield - - - - - -
Capitalization / Revenue 1.6 x 1.66 x 6.81 x 9.17 x 9.19 x 3.93 x
EV / Revenue 3.6 x 6.04 x 14.7 x 16.4 x 21.1 x 15.5 x
EV / EBITDA -2.02 x -1.92 x -4.01 x -8.06 x -7.62 x -3.26 x
EV / FCF -1.8 x -4.29 x -5.03 x -3.13 x -7.97 x -2.64 x
FCF Yield -55.6% -23.3% -19.9% -32% -12.6% -37.9%
Price to Book -0.62 x -0.26 x -0.52 x -0.95 x -0.54 x -0.36 x
Nbr of stocks (in thousands) 1,752 2,400 3,919 7,945 12,221 23,543
Reference price 2 2.250 1.250 2.120 2.310 1.300 0.3300
Announcement Date 19-04-16 20-04-14 21-04-15 22-04-05 23-04-12 24-06-07
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 2.458 1.81 1.221 2.002 1.729 1.978
EBITDA 1 -4.383 -5.682 -4.458 -4.075 -4.779 -9.391
EBIT 1 -4.477 -5.806 -4.586 -4.185 -4.898 -9.503
Operating Margin -182.15% -320.75% -375.7% -209.01% -283.25% -480.51%
Earnings before Tax (EBT) 1 -9.699 -11.88 -16.01 -20.15 -16.08 -29.31
Net income 1 -9.699 -11.66 -16.01 -20.15 -16.08 -29.31
Net margin -394.62% -644.25% -1,311.29% -1,006.48% -929.64% -1,482.19%
EPS 2 -15.33 -7.984 -5.322 -3.418 -1.610 -1.508
Free Cash Flow 1 -4.916 -2.547 -3.559 -10.51 -4.57 -11.58
FCF margin -200.02% -140.74% -291.57% -524.7% -264.28% -585.6%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 19-04-16 20-04-14 21-04-15 22-04-05 23-04-12 24-06-07
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 4.9 7.93 9.58 14.5 20.5 22.8
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) -1.118 x -1.395 x -2.148 x -3.561 x -4.295 x -2.428 x
Free Cash Flow 1 -4.92 -2.55 -3.56 -10.5 -4.57 -11.6
ROE (net income / shareholders' equity) 93.5% 128% 110% 103% 58.6% 89.6%
ROA (Net income/ Total Assets) -123% -172% -139% -102% -126% -388%
Assets 1 7.903 6.774 11.5 19.78 12.71 7.549
Book Value Per Share 2 -3.640 -4.730 -4.060 -2.440 -2.390 -0.9300
Cash Flow per Share 2 0.0600 0.0100 0 0.0100 0 0
Capex - 0.02 0 0.12 0.02 0.01
Capex / Sales - 1.29% 0.14% 6.14% 1.2% 0.38%
Announcement Date 19-04-16 20-04-14 21-04-15 22-04-05 23-04-12 24-06-07
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
PRESSURE BIOSCIENCES, INC. Stock Pressure BioSciences, Inc.
-61.42% 4.42M
ABBOTT LABORATORIES Stock Abbott Laboratories
-5.60% 181B
MEDTRONIC PLC Stock Medtronic plc
-4.45% 101B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-4.15% 67.54B
DEXCOM, INC. Stock DexCom, Inc.
-8.63% 45.09B
CENCORA, INC. Stock Cencora, Inc.
+9.70% 44.37B
HOYA CORPORATION Stock Hoya Corporation
+6.35% 40.7B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+15.22% 29.85B
TERUMO CORPORATION Stock Terumo Corporation
+11.99% 24.49B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-6.46% 23.99B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. PBIO Stock
  4. Financials Pressure BioSciences, Inc.